Reuters logo
BRIEF-Kite Pharma says one patient in KTE-C19 study died
May 8, 2017 / 1:12 PM / 7 months ago

BRIEF-Kite Pharma says one patient in KTE-C19 study died

May 8 (Reuters) - Kite Pharma Inc

* Kite says one patient in safety study testing cancer drug, KTE-C19, developed multiple organ failure and then fatal cerebral edema: conf call Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below